Researcher
Leen HEYENS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Immunology not elsewhere classified, General diagnostics, Endocrinology, Metabolic diseases, Hepatology, Hepatology (incl. pancreas)
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Aug 2019 → Today - Immunology - Biochemistry (Research group)
Member
From1 Aug 2019 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Aug 2019 → 31 Dec 2019
Projects
1 - 2 of 2
- Development of an evidence based proof of concept care path for Non-Alcoholic Fatty Liver disease in Flanders.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- : Development of an evidence based proof of concept care path for Non-Alcoholic Fatty Liver disease in Flanders.From1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 15
- SKIN AUTOFLUORESCENCE IS ASSOCIATED WITH FIB-4, FORNS AND FATTY LIVER INDEX - THE MAASTRICHT STUDY(2023)
Authors: Leen HEYENS, Hanna Kenjic, Pieter Dagnelie, Casper Schalkwijk, Coen Stehouwer, Steven Meex, Jeroen Kooman, Otto Bekers, Marleen Van Greevenbroek, Hans Savelberg, et al.
Pages: S882 - Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe(2023)
Authors: Sophia Papadakis, Marilena Anastasaki, Irini Gergianaki, Ger Koek, Juan Mendive, Foteini Anastasiou, Leen HEYENS, Montserrat Garcia-Retortillo, Jean Muris, Christos Lionis
- FIRST RESULTS OF THE EVOLUTION AND THE INFLUENCE OF STATIN TREATMENT ON NAFLD IN A PRIMARY CARE COHORT OVER A 2-YEAR PERIOD(2023)
Authors: Leen HEYENS, Wouter ROBAEYS, Liesbet Vernijns, Anneleen Robaeys, Sven Francque, Geert ROBAEYS
Pages: S961 - S962 - The effect of standard of care lifestyle advice by a hepatologist in a routine clinical practice on steatosis and fibrosis development among NAFLD patients(2023)
Authors: Leen HEYENS, Wouter ROBAEYS, Mathieu Struyve, Gert Stockmans, Sven Francque, Geert ROBAEYS
Pages: S828 - S829 - PREVALENCE OF NAFLD AND ACCURACY OF NITS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME(2023)
Authors: Wouter ROBAEYS, Leen HEYENS, Nathalie Dhont, Geert VERSWIJVEL, Ger H. Koek, Geert ROBAEYS, Struyve Mathieu, Joris PENDERS, Sven Francque
Pages: S1032 - S1033 - Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis(2022)
Authors: Dana BUSSCHOTS, Cécile KREMER, Rob BIELEN, Ozgur KOC, Leen HEYENS, Frederik Nevens, Niel HENS, Geert ROBAEYS
- The fibrosis-4 cut-off value for significant fibrosis is dependent on the type of non-alcoholic fatty liver disease patients(2022)
Authors: Leen HEYENS, Wouter ROBAEYS, Christophe Van Steenkiste, Sven Francque, Geert ROBAEYS
Pages: S459 - S460 - Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment(2021)
Authors: Leen HEYENS, Dana BUSSCHOTS, Ger H. Koek, Geert ROBAEYS, Sven Francque
- Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium(2021)
Authors: Dana BUSSCHOTS, Cécile KREMER, Rob BIELEN, Ozgur KOC, Leen HEYENS, Eefje DERCON, R Verrando, T Windelinckx, G Maertens, S Bourgeois, et al.
- The hepatitis C cascade of care in the Belgian HIV population: one step closer to elimination(2021)
Authors: Dana BUSSCHOTS, Cécile KREMER, Ozgur KOC, Leen HEYENS, Rob BIELEN, Ludwig Apers, Eric Florence, Peter MESSIAEN, Kristel Van Laethem, Eric Van Wijngaerden, et al.
Pages: 217 - 223